Corizon | St. Louis Public Radio

Corizon

Donald Hutson died after taking synthetic cannabinoids, or K2, at Missouri Eastern Correctional Center in 2018. An internal investigation by the Missouri Department of Corrections revealed officers did not follow departmental policy while restraining him.
Carolina Hidalgo | St. Louis Public Radio

Donald Hutson’s family had been waiting for his release from prison for decades.

But in September 2018, Hutson died at Missouri Eastern Correctional Center after taking the illegal drug K2.

St. Louis Public Radio first reported on his death last year as part of a long-term investigation examining overdoses in Missouri prisons. Our reporting uncovered disturbing details about the night Hutson died, spurring more questions. 

Thomas Hawk | Flickr

The ACLU and the MacArthur Justice Center of Missouri are asking a judge to order the expedited treatment of prison inmates infected with the hepatitis C virus. 

They’ve filed a class-action lawsuit against the Missouri Department of Corrections and its private medical provider, Corizon, but that may not get started for another year. 

Eastern Reception Diagnostic and Corrections Center in Bonne Terre, Missouri.
File photo | Willis Ryder Arnold | St. Louis Public Radio

A federal appeals court will soon decide whether Missouri inmates with hepatitis C will be included in a class-action lawsuit seeking treatment for thousands of other state prisoners.

The American Civil Liberties Union and the MacArthur Justice Center filed a federal lawsuit against the Missouri Department of Corrections and prison health-care provider Corizon in December 2016. The lawsuit, brought on behalf of three inmates with hepatitis C, claims the department’s policy of only treating people with the most serious symptoms of the virus constitutes cruel and unusual punishment and violates the Eighth Amendment.